ArticleMedical oncology (Northwood, London, England)2023

Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.

Kayla V Myers Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.